Are you Dr. Singhal?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 65 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1 Union St
Suite 101
Robbinsville, NJ 08691Phone+1 609-890-7292Fax+1 215-860-8950- Is this information wrong?
Summary
- Dr. Shalabh Singhal, MD is a cardiologist in Robbinsville, New Jersey. He is currently licensed to practice medicine in New Jersey, Indiana, and Ohio.
Education & Training
University of Cincinnati Medical Center/College of MedicineFellowship, Cardiovascular Disease, 2006 - 2009
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2003 - 2006
SUNY Upstate Medical UniversityClass of 2003
Certifications & Licensure
NJ State Medical License 2013 - 2025
PA State Medical License 2003 - 2016
IN State Medical License 2009 - 2013
OH State Medical License 2006 - 2010
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsAbsolute and Relative Bioavailability of Oral Solid Dosage Formulations of Deucravacitinib in Humans.Anjaneya Chimalakonda, Wenying Li, David Marchisin, Bing He, Shalabh Singhal, Prashant Deshpande, Jonathan Brown, Urvi Aras, Bindu Murthy> ;Clinical Pharmacology in Drug Development. 2023 Oct 1
- 43 citationsDeucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.Eric Morand, Marilyn Pike, Joan T Merrill, Ronald van Vollenhoven, Victoria P Werth, Coburn Hobar, Nikolay Delev, Vaishali Shah, Brian Sharkey, Thomas Wegman, Ian Catl...> ;Arthritis & Rheumatology. 2023 Feb 1
- 75 citationsEfficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis.Philip J Mease, Atul A Deodhar, Désirée van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak, Subhashis Banerjee> ;Annals of the Rheumatic Diseases. 2022 Jun 1
- Join now to see all
Professional Memberships
- Member
